Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| PR150338 | Other Grant/Funding Number | Congressionally Directed Medical Research Program |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Houston | OTHER |
Not provided
Not provided
Not provided
The goal of this study is to develop a new way to assess skin thickness in patients with scleroderma (systemic sclerosis). The study will test how well a new imaging method called optical coherence elastography (OCE) compares to the current clinical method used to estimate skin thickness, the modified Rodnan Skin Score (mRSS).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Optical Elastography Assessment of Skin Thickness |
| ||
| Visual Assessment of Skin Thickness |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Optical Elastography | Device | To image skin thickness, Optical Coherence Elastography (OCE)-scanning of 6 body surface areas will be preformed using the Phase-Stabilized Swept Source Optical Coherence Elastography (PhS-SSOCE) system. |
| Measure | Description | Time Frame |
|---|---|---|
| Skin optical elastography (OCE) scan score | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Skin thickness as assessed by Modified Rodnan Skin Score (mRSS) | Baseline | |
| Fibrosis score as assessed by forearm skin punch biopsy | A score based on histological findings of skin punch biopsy will be calculated. There some minor risk involved with skin biopsy procedure. |
Not provided
Inclusion Criteria for scleroderma patients:
Exclusion Criteria:
Not provided
Not provided
Patients seen in clinic.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Shervin Assassi, MD | The University of Texas Health Science Center, Houston | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D045743 | Scleroderma, Diffuse |
| ID | Term |
|---|---|
| D012595 | Scleroderma, Systemic |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006804 | Ergonomics |
| ID | Term |
|---|---|
| D004738 | Engineering |
| D013676 | Technology, Industry, and Agriculture |
Not provided
Not provided
Not provided
Not provided
Not provided
skin punch biopsy
| Visual Assessment | Other | Skin thickness will be visually assessed clinically in 6 body surface areas using the the modified Rodnan Skin Score (mRSS). The mRSS uses a 0-3 scale, where 0 = normal, 1= mild thickness, 2 = moderate thickness, and 3 = severe thickness |
|
| Baseline |
| Disability as assessed by the Scleroderma Health Assessment Questionnaire | Baseline |